Global Oncology & Cancer Drugs Supply, Demand and Key Producers, 2023-2029

Page: 132

Published Date: 29 Jan 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Related Reports
Product Tags

Description

The global Oncology & Cancer Drugs market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Cancer is the name given to a group of related diseases characterized by the uncontrolled and excessive growth of abnormal cells. More than 200 different types of cancer have been identified.  When these extra cells form a mass or a solid lump of tissue, it is called a tumor. Most cancers form tumors, but not all do. Tumors may be either benign or cancerous.

This report studies the global Oncology & Cancer Drugs production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Oncology & Cancer Drugs, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Oncology & Cancer Drugs that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Oncology & Cancer Drugs total production and demand, 2018-2029, (K Units)
Global Oncology & Cancer Drugs total production value, 2018-2029, (USD Million)
Global Oncology & Cancer Drugs production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Oncology & Cancer Drugs consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Oncology & Cancer Drugs domestic production, consumption, key domestic manufacturers and share
Global Oncology & Cancer Drugs production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Oncology & Cancer Drugs production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Oncology & Cancer Drugs production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Oncology & Cancer Drugs market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Celgene, Novartis, Bristol-Myers Squibb, Johnson & Johnson, Merck & Co., AstraZeneca, Pfizer and Amgen, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Oncology & Cancer Drugs market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Oncology & Cancer Drugs Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Oncology & Cancer Drugs Market, Segmentation by Type
    Chemotherapy
    Targeted Therapy
    Immunotherapy (Biologic Therapy)
    Hormonal Therapy
    Others

Global Oncology & Cancer Drugs Market, Segmentation by Application
    Blood Cancer
    Breast Cancer
    Gastrointestinal Cancer
    Prostate Cancer
    Respiratory/Lung Cancer
    Others

Companies Profiled:
    Roche
    Celgene
    Novartis
    Bristol-Myers Squibb
    Johnson & Johnson
    Merck & Co.
    AstraZeneca
    Pfizer
    Amgen
    Eli Lilly
    AbbVie
    Takeda
    Astellas
    Ipsen
    Sanofi
    Bayer
    Biogen Idec
    Teva
    Otsuka
    Eisai
    Merck KGaA
    Gilead Sciences

Key Questions Answered
1. How big is the global Oncology & Cancer Drugs market?
2. What is the demand of the global Oncology & Cancer Drugs market?
3. What is the year over year growth of the global Oncology & Cancer Drugs market?
4. What is the production and production value of the global Oncology & Cancer Drugs market?
5. Who are the key producers in the global Oncology & Cancer Drugs market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Oncology & Cancer Drugs Introduction
    1.2 World Oncology & Cancer Drugs Supply & Forecast
        1.2.1 World Oncology & Cancer Drugs Production Value (2018 & 2022 & 2029)
        1.2.2 World Oncology & Cancer Drugs Production (2018-2029)
        1.2.3 World Oncology & Cancer Drugs Pricing Trends (2018-2029)
    1.3 World Oncology & Cancer Drugs Production by Region (Based on Production Site)
        1.3.1 World Oncology & Cancer Drugs Production Value by Region (2018-2029)
        1.3.2 World Oncology & Cancer Drugs Production by Region (2018-2029)
        1.3.3 World Oncology & Cancer Drugs Average Price by Region (2018-2029)
        1.3.4 North America Oncology & Cancer Drugs Production (2018-2029)
        1.3.5 Europe Oncology & Cancer Drugs Production (2018-2029)
        1.3.6 China Oncology & Cancer Drugs Production (2018-2029)
        1.3.7 Japan Oncology & Cancer Drugs Production (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Oncology & Cancer Drugs Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Oncology & Cancer Drugs Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Oncology & Cancer Drugs Demand (2018-2029)
    2.2 World Oncology & Cancer Drugs Consumption by Region
        2.2.1 World Oncology & Cancer Drugs Consumption by Region (2018-2023)
        2.2.2 World Oncology & Cancer Drugs Consumption Forecast by Region (2024-2029)
    2.3 United States Oncology & Cancer Drugs Consumption (2018-2029)
    2.4 China Oncology & Cancer Drugs Consumption (2018-2029)
    2.5 Europe Oncology & Cancer Drugs Consumption (2018-2029)
    2.6 Japan Oncology & Cancer Drugs Consumption (2018-2029)
    2.7 South Korea Oncology & Cancer Drugs Consumption (2018-2029)
    2.8 ASEAN Oncology & Cancer Drugs Consumption (2018-2029)
    2.9 India Oncology & Cancer Drugs Consumption (2018-2029)

3 World Oncology & Cancer Drugs Manufacturers Competitive Analysis
    3.1 World Oncology & Cancer Drugs Production Value by Manufacturer (2018-2023)
    3.2 World Oncology & Cancer Drugs Production by Manufacturer (2018-2023)
    3.3 World Oncology & Cancer Drugs Average Price by Manufacturer (2018-2023)
    3.4 Oncology & Cancer Drugs Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Oncology & Cancer Drugs Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Oncology & Cancer Drugs in 2022
        3.5.3 Global Concentration Ratios (CR8) for Oncology & Cancer Drugs in 2022
    3.6 Oncology & Cancer Drugs Market: Overall Company Footprint Analysis
        3.6.1 Oncology & Cancer Drugs Market: Region Footprint
        3.6.2 Oncology & Cancer Drugs Market: Company Product Type Footprint
        3.6.3 Oncology & Cancer Drugs Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Oncology & Cancer Drugs Production Value Comparison
        4.1.1 United States VS China: Oncology & Cancer Drugs Production Value Comparison (2018 & 2022 & 2029)
        4.1.2 United States VS China: Oncology & Cancer Drugs Production Value Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States VS China: Oncology & Cancer Drugs Production Comparison
        4.2.1 United States VS China: Oncology & Cancer Drugs Production Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Oncology & Cancer Drugs Production Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States VS China: Oncology & Cancer Drugs Consumption Comparison
        4.3.1 United States VS China: Oncology & Cancer Drugs Consumption Comparison (2018 & 2022 & 2029)
        4.3.2 United States VS China: Oncology & Cancer Drugs Consumption Market Share Comparison (2018 & 2022 & 2029)
    4.4 United States Based Oncology & Cancer Drugs Manufacturers and Market Share, 2018-2023
        4.4.1 United States Based Oncology & Cancer Drugs Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Oncology & Cancer Drugs Production Value (2018-2023)
        4.4.3 United States Based Manufacturers Oncology & Cancer Drugs Production (2018-2023)
    4.5 China Based Oncology & Cancer Drugs Manufacturers and Market Share
        4.5.1 China Based Oncology & Cancer Drugs Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Oncology & Cancer Drugs Production Value (2018-2023)
        4.5.3 China Based Manufacturers Oncology & Cancer Drugs Production (2018-2023)
    4.6 Rest of World Based Oncology & Cancer Drugs Manufacturers and Market Share, 2018-2023
        4.6.1 Rest of World Based Oncology & Cancer Drugs Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Oncology & Cancer Drugs Production Value (2018-2023)
        4.6.3 Rest of World Based Manufacturers Oncology & Cancer Drugs Production (2018-2023)

5 Market Analysis by Type
    5.1 World Oncology & Cancer Drugs Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Chemotherapy
        5.2.2 Targeted Therapy
        5.2.3 Immunotherapy (Biologic Therapy)
        5.2.4 Hormonal Therapy
        5.2.5 Others
    5.3 Market Segment by Type
        5.3.1 World Oncology & Cancer Drugs Production by Type (2018-2029)
        5.3.2 World Oncology & Cancer Drugs Production Value by Type (2018-2029)
        5.3.3 World Oncology & Cancer Drugs Average Price by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Oncology & Cancer Drugs Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Blood Cancer
        6.2.2 Breast Cancer
        6.2.3 Gastrointestinal Cancer
        6.2.4 Prostate Cancer
        6.2.5 Respiratory/Lung Cancer
        6.2.6 Others
    6.3 Market Segment by Application
        6.3.1 World Oncology & Cancer Drugs Production by Application (2018-2029)
        6.3.2 World Oncology & Cancer Drugs Production Value by Application (2018-2029)
        6.3.3 World Oncology & Cancer Drugs Average Price by Application (2018-2029)

7 Company Profiles
    7.1 Roche
        7.1.1 Roche Details
        7.1.2 Roche Major Business
        7.1.3 Roche Oncology & Cancer Drugs Product and Services
        7.1.4 Roche Oncology & Cancer Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.1.5 Roche Recent Developments/Updates
        7.1.6 Roche Competitive Strengths & Weaknesses
    7.2 Celgene
        7.2.1 Celgene Details
        7.2.2 Celgene Major Business
        7.2.3 Celgene Oncology & Cancer Drugs Product and Services
        7.2.4 Celgene Oncology & Cancer Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.2.5 Celgene Recent Developments/Updates
        7.2.6 Celgene Competitive Strengths & Weaknesses
    7.3 Novartis
        7.3.1 Novartis Details
        7.3.2 Novartis Major Business
        7.3.3 Novartis Oncology & Cancer Drugs Product and Services
        7.3.4 Novartis Oncology & Cancer Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.3.5 Novartis Recent Developments/Updates
        7.3.6 Novartis Competitive Strengths & Weaknesses
    7.4 Bristol-Myers Squibb
        7.4.1 Bristol-Myers Squibb Details
        7.4.2 Bristol-Myers Squibb Major Business
        7.4.3 Bristol-Myers Squibb Oncology & Cancer Drugs Product and Services
        7.4.4 Bristol-Myers Squibb Oncology & Cancer Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.4.5 Bristol-Myers Squibb Recent Developments/Updates
        7.4.6 Bristol-Myers Squibb Competitive Strengths & Weaknesses
    7.5 Johnson & Johnson
        7.5.1 Johnson & Johnson Details
        7.5.2 Johnson & Johnson Major Business
        7.5.3 Johnson & Johnson Oncology & Cancer Drugs Product and Services
        7.5.4 Johnson & Johnson Oncology & Cancer Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.5.5 Johnson & Johnson Recent Developments/Updates
        7.5.6 Johnson & Johnson Competitive Strengths & Weaknesses
    7.6 Merck & Co.
        7.6.1 Merck & Co. Details
        7.6.2 Merck & Co. Major Business
        7.6.3 Merck & Co. Oncology & Cancer Drugs Product and Services
        7.6.4 Merck & Co. Oncology & Cancer Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.6.5 Merck & Co. Recent Developments/Updates
        7.6.6 Merck & Co. Competitive Strengths & Weaknesses
    7.7 AstraZeneca
        7.7.1 AstraZeneca Details
        7.7.2 AstraZeneca Major Business
        7.7.3 AstraZeneca Oncology & Cancer Drugs Product and Services
        7.7.4 AstraZeneca Oncology & Cancer Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.7.5 AstraZeneca Recent Developments/Updates
        7.7.6 AstraZeneca Competitive Strengths & Weaknesses
    7.8 Pfizer
        7.8.1 Pfizer Details
        7.8.2 Pfizer Major Business
        7.8.3 Pfizer Oncology & Cancer Drugs Product and Services
        7.8.4 Pfizer Oncology & Cancer Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.8.5 Pfizer Recent Developments/Updates
        7.8.6 Pfizer Competitive Strengths & Weaknesses
    7.9 Amgen
        7.9.1 Amgen Details
        7.9.2 Amgen Major Business
        7.9.3 Amgen Oncology & Cancer Drugs Product and Services
        7.9.4 Amgen Oncology & Cancer Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.9.5 Amgen Recent Developments/Updates
        7.9.6 Amgen Competitive Strengths & Weaknesses
    7.10 Eli Lilly
        7.10.1 Eli Lilly Details
        7.10.2 Eli Lilly Major Business
        7.10.3 Eli Lilly Oncology & Cancer Drugs Product and Services
        7.10.4 Eli Lilly Oncology & Cancer Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.10.5 Eli Lilly Recent Developments/Updates
        7.10.6 Eli Lilly Competitive Strengths & Weaknesses
    7.11 AbbVie
        7.11.1 AbbVie Details
        7.11.2 AbbVie Major Business
        7.11.3 AbbVie Oncology & Cancer Drugs Product and Services
        7.11.4 AbbVie Oncology & Cancer Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.11.5 AbbVie Recent Developments/Updates
        7.11.6 AbbVie Competitive Strengths & Weaknesses
    7.12 Takeda
        7.12.1 Takeda Details
        7.12.2 Takeda Major Business
        7.12.3 Takeda Oncology & Cancer Drugs Product and Services
        7.12.4 Takeda Oncology & Cancer Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.12.5 Takeda Recent Developments/Updates
        7.12.6 Takeda Competitive Strengths & Weaknesses
    7.13 Astellas
        7.13.1 Astellas Details
        7.13.2 Astellas Major Business
        7.13.3 Astellas Oncology & Cancer Drugs Product and Services
        7.13.4 Astellas Oncology & Cancer Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.13.5 Astellas Recent Developments/Updates
        7.13.6 Astellas Competitive Strengths & Weaknesses
    7.14 Ipsen
        7.14.1 Ipsen Details
        7.14.2 Ipsen Major Business
        7.14.3 Ipsen Oncology & Cancer Drugs Product and Services
        7.14.4 Ipsen Oncology & Cancer Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.14.5 Ipsen Recent Developments/Updates
        7.14.6 Ipsen Competitive Strengths & Weaknesses
    7.15 Sanofi
        7.15.1 Sanofi Details
        7.15.2 Sanofi Major Business
        7.15.3 Sanofi Oncology & Cancer Drugs Product and Services
        7.15.4 Sanofi Oncology & Cancer Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.15.5 Sanofi Recent Developments/Updates
        7.15.6 Sanofi Competitive Strengths & Weaknesses
    7.16 Bayer
        7.16.1 Bayer Details
        7.16.2 Bayer Major Business
        7.16.3 Bayer Oncology & Cancer Drugs Product and Services
        7.16.4 Bayer Oncology & Cancer Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.16.5 Bayer Recent Developments/Updates
        7.16.6 Bayer Competitive Strengths & Weaknesses
    7.17 Biogen Idec
        7.17.1 Biogen Idec Details
        7.17.2 Biogen Idec Major Business
        7.17.3 Biogen Idec Oncology & Cancer Drugs Product and Services
        7.17.4 Biogen Idec Oncology & Cancer Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.17.5 Biogen Idec Recent Developments/Updates
        7.17.6 Biogen Idec Competitive Strengths & Weaknesses
    7.18 Teva
        7.18.1 Teva Details
        7.18.2 Teva Major Business
        7.18.3 Teva Oncology & Cancer Drugs Product and Services
        7.18.4 Teva Oncology & Cancer Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.18.5 Teva Recent Developments/Updates
        7.18.6 Teva Competitive Strengths & Weaknesses
    7.19 Otsuka
        7.19.1 Otsuka Details
        7.19.2 Otsuka Major Business
        7.19.3 Otsuka Oncology & Cancer Drugs Product and Services
        7.19.4 Otsuka Oncology & Cancer Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.19.5 Otsuka Recent Developments/Updates
        7.19.6 Otsuka Competitive Strengths & Weaknesses
    7.20 Eisai
        7.20.1 Eisai Details
        7.20.2 Eisai Major Business
        7.20.3 Eisai Oncology & Cancer Drugs Product and Services
        7.20.4 Eisai Oncology & Cancer Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.20.5 Eisai Recent Developments/Updates
        7.20.6 Eisai Competitive Strengths & Weaknesses
    7.21 Merck KGaA
        7.21.1 Merck KGaA Details
        7.21.2 Merck KGaA Major Business
        7.21.3 Merck KGaA Oncology & Cancer Drugs Product and Services
        7.21.4 Merck KGaA Oncology & Cancer Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.21.5 Merck KGaA Recent Developments/Updates
        7.21.6 Merck KGaA Competitive Strengths & Weaknesses
    7.22 Gilead Sciences
        7.22.1 Gilead Sciences Details
        7.22.2 Gilead Sciences Major Business
        7.22.3 Gilead Sciences Oncology & Cancer Drugs Product and Services
        7.22.4 Gilead Sciences Oncology & Cancer Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.22.5 Gilead Sciences Recent Developments/Updates
        7.22.6 Gilead Sciences Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Oncology & Cancer Drugs Industry Chain
    8.2 Oncology & Cancer Drugs Upstream Analysis
        8.2.1 Oncology & Cancer Drugs Core Raw Materials
        8.2.2 Main Manufacturers of Oncology & Cancer Drugs Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Oncology & Cancer Drugs Production Mode
    8.6 Oncology & Cancer Drugs Procurement Model
    8.7 Oncology & Cancer Drugs Industry Sales Model and Sales Channels
        8.7.1 Oncology & Cancer Drugs Sales Model
        8.7.2 Oncology & Cancer Drugs Typical Customers

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Oncology & Cancer Drugs Production Value by Region (2018, 2022 and 2029) & (USD Million)
    Table 2. World Oncology & Cancer Drugs Production Value by Region (2018-2023) & (USD Million)
    Table 3. World Oncology & Cancer Drugs Production Value by Region (2024-2029) & (USD Million)
    Table 4. World Oncology & Cancer Drugs Production Value Market Share by Region (2018-2023)
    Table 5. World Oncology & Cancer Drugs Production Value Market Share by Region (2024-2029)
    Table 6. World Oncology & Cancer Drugs Production by Region (2018-2023) & (K Units)
    Table 7. World Oncology & Cancer Drugs Production by Region (2024-2029) & (K Units)
    Table 8. World Oncology & Cancer Drugs Production Market Share by Region (2018-2023)
    Table 9. World Oncology & Cancer Drugs Production Market Share by Region (2024-2029)
    Table 10. World Oncology & Cancer Drugs Average Price by Region (2018-2023) & (US$/Unit)
    Table 11. World Oncology & Cancer Drugs Average Price by Region (2024-2029) & (US$/Unit)
    Table 12. Oncology & Cancer Drugs Major Market Trends
    Table 13. World Oncology & Cancer Drugs Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
    Table 14. World Oncology & Cancer Drugs Consumption by Region (2018-2023) & (K Units)
    Table 15. World Oncology & Cancer Drugs Consumption Forecast by Region (2024-2029) & (K Units)
    Table 16. World Oncology & Cancer Drugs Production Value by Manufacturer (2018-2023) & (USD Million)
    Table 17. Production Value Market Share of Key Oncology & Cancer Drugs Producers in 2022
    Table 18. World Oncology & Cancer Drugs Production by Manufacturer (2018-2023) & (K Units)
    Table 19. Production Market Share of Key Oncology & Cancer Drugs Producers in 2022
    Table 20. World Oncology & Cancer Drugs Average Price by Manufacturer (2018-2023) & (US$/Unit)
    Table 21. Global Oncology & Cancer Drugs Company Evaluation Quadrant
    Table 22. World Oncology & Cancer Drugs Industry Rank of Major Manufacturers, Based on Production Value in 2022
    Table 23. Head Office and Oncology & Cancer Drugs Production Site of Key Manufacturer
    Table 24. Oncology & Cancer Drugs Market: Company Product Type Footprint
    Table 25. Oncology & Cancer Drugs Market: Company Product Application Footprint
    Table 26. Oncology & Cancer Drugs Competitive Factors
    Table 27. Oncology & Cancer Drugs New Entrant and Capacity Expansion Plans
    Table 28. Oncology & Cancer Drugs Mergers & Acquisitions Activity
    Table 29. United States VS China Oncology & Cancer Drugs Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 30. United States VS China Oncology & Cancer Drugs Production Comparison, (2018 & 2022 & 2029) & (K Units)
    Table 31. United States VS China Oncology & Cancer Drugs Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
    Table 32. United States Based Oncology & Cancer Drugs Manufacturers, Headquarters and Production Site (States, Country)
    Table 33. United States Based Manufacturers Oncology & Cancer Drugs Production Value, (2018-2023) & (USD Million)
    Table 34. United States Based Manufacturers Oncology & Cancer Drugs Production Value Market Share (2018-2023)
    Table 35. United States Based Manufacturers Oncology & Cancer Drugs Production (2018-2023) & (K Units)
    Table 36. United States Based Manufacturers Oncology & Cancer Drugs Production Market Share (2018-2023)
    Table 37. China Based Oncology & Cancer Drugs Manufacturers, Headquarters and Production Site (Province, Country)
    Table 38. China Based Manufacturers Oncology & Cancer Drugs Production Value, (2018-2023) & (USD Million)
    Table 39. China Based Manufacturers Oncology & Cancer Drugs Production Value Market Share (2018-2023)
    Table 40. China Based Manufacturers Oncology & Cancer Drugs Production (2018-2023) & (K Units)
    Table 41. China Based Manufacturers Oncology & Cancer Drugs Production Market Share (2018-2023)
    Table 42. Rest of World Based Oncology & Cancer Drugs Manufacturers, Headquarters and Production Site (States, Country)
    Table 43. Rest of World Based Manufacturers Oncology & Cancer Drugs Production Value, (2018-2023) & (USD Million)
    Table 44. Rest of World Based Manufacturers Oncology & Cancer Drugs Production Value Market Share (2018-2023)
    Table 45. Rest of World Based Manufacturers Oncology & Cancer Drugs Production (2018-2023) & (K Units)
    Table 46. Rest of World Based Manufacturers Oncology & Cancer Drugs Production Market Share (2018-2023)
    Table 47. World Oncology & Cancer Drugs Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 48. World Oncology & Cancer Drugs Production by Type (2018-2023) & (K Units)
    Table 49. World Oncology & Cancer Drugs Production by Type (2024-2029) & (K Units)
    Table 50. World Oncology & Cancer Drugs Production Value by Type (2018-2023) & (USD Million)
    Table 51. World Oncology & Cancer Drugs Production Value by Type (2024-2029) & (USD Million)
    Table 52. World Oncology & Cancer Drugs Average Price by Type (2018-2023) & (US$/Unit)
    Table 53. World Oncology & Cancer Drugs Average Price by Type (2024-2029) & (US$/Unit)
    Table 54. World Oncology & Cancer Drugs Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 55. World Oncology & Cancer Drugs Production by Application (2018-2023) & (K Units)
    Table 56. World Oncology & Cancer Drugs Production by Application (2024-2029) & (K Units)
    Table 57. World Oncology & Cancer Drugs Production Value by Application (2018-2023) & (USD Million)
    Table 58. World Oncology & Cancer Drugs Production Value by Application (2024-2029) & (USD Million)
    Table 59. World Oncology & Cancer Drugs Average Price by Application (2018-2023) & (US$/Unit)
    Table 60. World Oncology & Cancer Drugs Average Price by Application (2024-2029) & (US$/Unit)
    Table 61. Roche Basic Information, Manufacturing Base and Competitors
    Table 62. Roche Major Business
    Table 63. Roche Oncology & Cancer Drugs Product and Services
    Table 64. Roche Oncology & Cancer Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 65. Roche Recent Developments/Updates
    Table 66. Roche Competitive Strengths & Weaknesses
    Table 67. Celgene Basic Information, Manufacturing Base and Competitors
    Table 68. Celgene Major Business
    Table 69. Celgene Oncology & Cancer Drugs Product and Services
    Table 70. Celgene Oncology & Cancer Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 71. Celgene Recent Developments/Updates
    Table 72. Celgene Competitive Strengths & Weaknesses
    Table 73. Novartis Basic Information, Manufacturing Base and Competitors
    Table 74. Novartis Major Business
    Table 75. Novartis Oncology & Cancer Drugs Product and Services
    Table 76. Novartis Oncology & Cancer Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 77. Novartis Recent Developments/Updates
    Table 78. Novartis Competitive Strengths & Weaknesses
    Table 79. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
    Table 80. Bristol-Myers Squibb Major Business
    Table 81. Bristol-Myers Squibb Oncology & Cancer Drugs Product and Services
    Table 82. Bristol-Myers Squibb Oncology & Cancer Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 83. Bristol-Myers Squibb Recent Developments/Updates
    Table 84. Bristol-Myers Squibb Competitive Strengths & Weaknesses
    Table 85. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
    Table 86. Johnson & Johnson Major Business
    Table 87. Johnson & Johnson Oncology & Cancer Drugs Product and Services
    Table 88. Johnson & Johnson Oncology & Cancer Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 89. Johnson & Johnson Recent Developments/Updates
    Table 90. Johnson & Johnson Competitive Strengths & Weaknesses
    Table 91. Merck & Co. Basic Information, Manufacturing Base and Competitors
    Table 92. Merck & Co. Major Business
    Table 93. Merck & Co. Oncology & Cancer Drugs Product and Services
    Table 94. Merck & Co. Oncology & Cancer Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 95. Merck & Co. Recent Developments/Updates
    Table 96. Merck & Co. Competitive Strengths & Weaknesses
    Table 97. AstraZeneca Basic Information, Manufacturing Base and Competitors
    Table 98. AstraZeneca Major Business
    Table 99. AstraZeneca Oncology & Cancer Drugs Product and Services
    Table 100. AstraZeneca Oncology & Cancer Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 101. AstraZeneca Recent Developments/Updates
    Table 102. AstraZeneca Competitive Strengths & Weaknesses
    Table 103. Pfizer Basic Information, Manufacturing Base and Competitors
    Table 104. Pfizer Major Business
    Table 105. Pfizer Oncology & Cancer Drugs Product and Services
    Table 106. Pfizer Oncology & Cancer Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 107. Pfizer Recent Developments/Updates
    Table 108. Pfizer Competitive Strengths & Weaknesses
    Table 109. Amgen Basic Information, Manufacturing Base and Competitors
    Table 110. Amgen Major Business
    Table 111. Amgen Oncology & Cancer Drugs Product and Services
    Table 112. Amgen Oncology & Cancer Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 113. Amgen Recent Developments/Updates
    Table 114. Amgen Competitive Strengths & Weaknesses
    Table 115. Eli Lilly Basic Information, Manufacturing Base and Competitors
    Table 116. Eli Lilly Major Business
    Table 117. Eli Lilly Oncology & Cancer Drugs Product and Services
    Table 118. Eli Lilly Oncology & Cancer Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 119. Eli Lilly Recent Developments/Updates
    Table 120. Eli Lilly Competitive Strengths & Weaknesses
    Table 121. AbbVie Basic Information, Manufacturing Base and Competitors
    Table 122. AbbVie Major Business
    Table 123. AbbVie Oncology & Cancer Drugs Product and Services
    Table 124. AbbVie Oncology & Cancer Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 125. AbbVie Recent Developments/Updates
    Table 126. AbbVie Competitive Strengths & Weaknesses
    Table 127. Takeda Basic Information, Manufacturing Base and Competitors
    Table 128. Takeda Major Business
    Table 129. Takeda Oncology & Cancer Drugs Product and Services
    Table 130. Takeda Oncology & Cancer Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 131. Takeda Recent Developments/Updates
    Table 132. Takeda Competitive Strengths & Weaknesses
    Table 133. Astellas Basic Information, Manufacturing Base and Competitors
    Table 134. Astellas Major Business
    Table 135. Astellas Oncology & Cancer Drugs Product and Services
    Table 136. Astellas Oncology & Cancer Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 137. Astellas Recent Developments/Updates
    Table 138. Astellas Competitive Strengths & Weaknesses
    Table 139. Ipsen Basic Information, Manufacturing Base and Competitors
    Table 140. Ipsen Major Business
    Table 141. Ipsen Oncology & Cancer Drugs Product and Services
    Table 142. Ipsen Oncology & Cancer Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 143. Ipsen Recent Developments/Updates
    Table 144. Ipsen Competitive Strengths & Weaknesses
    Table 145. Sanofi Basic Information, Manufacturing Base and Competitors
    Table 146. Sanofi Major Business
    Table 147. Sanofi Oncology & Cancer Drugs Product and Services
    Table 148. Sanofi Oncology & Cancer Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 149. Sanofi Recent Developments/Updates
    Table 150. Sanofi Competitive Strengths & Weaknesses
    Table 151. Bayer Basic Information, Manufacturing Base and Competitors
    Table 152. Bayer Major Business
    Table 153. Bayer Oncology & Cancer Drugs Product and Services
    Table 154. Bayer Oncology & Cancer Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 155. Bayer Recent Developments/Updates
    Table 156. Bayer Competitive Strengths & Weaknesses
    Table 157. Biogen Idec Basic Information, Manufacturing Base and Competitors
    Table 158. Biogen Idec Major Business
    Table 159. Biogen Idec Oncology & Cancer Drugs Product and Services
    Table 160. Biogen Idec Oncology & Cancer Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 161. Biogen Idec Recent Developments/Updates
    Table 162. Biogen Idec Competitive Strengths & Weaknesses
    Table 163. Teva Basic Information, Manufacturing Base and Competitors
    Table 164. Teva Major Business
    Table 165. Teva Oncology & Cancer Drugs Product and Services
    Table 166. Teva Oncology & Cancer Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 167. Teva Recent Developments/Updates
    Table 168. Teva Competitive Strengths & Weaknesses
    Table 169. Otsuka Basic Information, Manufacturing Base and Competitors
    Table 170. Otsuka Major Business
    Table 171. Otsuka Oncology & Cancer Drugs Product and Services
    Table 172. Otsuka Oncology & Cancer Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 173. Otsuka Recent Developments/Updates
    Table 174. Otsuka Competitive Strengths & Weaknesses
    Table 175. Eisai Basic Information, Manufacturing Base and Competitors
    Table 176. Eisai Major Business
    Table 177. Eisai Oncology & Cancer Drugs Product and Services
    Table 178. Eisai Oncology & Cancer Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 179. Eisai Recent Developments/Updates
    Table 180. Eisai Competitive Strengths & Weaknesses
    Table 181. Merck KGaA Basic Information, Manufacturing Base and Competitors
    Table 182. Merck KGaA Major Business
    Table 183. Merck KGaA Oncology & Cancer Drugs Product and Services
    Table 184. Merck KGaA Oncology & Cancer Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 185. Merck KGaA Recent Developments/Updates
    Table 186. Gilead Sciences Basic Information, Manufacturing Base and Competitors
    Table 187. Gilead Sciences Major Business
    Table 188. Gilead Sciences Oncology & Cancer Drugs Product and Services
    Table 189. Gilead Sciences Oncology & Cancer Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 190. Global Key Players of Oncology & Cancer Drugs Upstream (Raw Materials)
    Table 191. Oncology & Cancer Drugs Typical Customers
    Table 192. Oncology & Cancer Drugs Typical Distributors
List of Figure
    Figure 1. Oncology & Cancer Drugs Picture
    Figure 2. World Oncology & Cancer Drugs Production Value: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Oncology & Cancer Drugs Production Value and Forecast (2018-2029) & (USD Million)
    Figure 4. World Oncology & Cancer Drugs Production (2018-2029) & (K Units)
    Figure 5. World Oncology & Cancer Drugs Average Price (2018-2029) & (US$/Unit)
    Figure 6. World Oncology & Cancer Drugs Production Value Market Share by Region (2018-2029)
    Figure 7. World Oncology & Cancer Drugs Production Market Share by Region (2018-2029)
    Figure 8. North America Oncology & Cancer Drugs Production (2018-2029) & (K Units)
    Figure 9. Europe Oncology & Cancer Drugs Production (2018-2029) & (K Units)
    Figure 10. China Oncology & Cancer Drugs Production (2018-2029) & (K Units)
    Figure 11. Japan Oncology & Cancer Drugs Production (2018-2029) & (K Units)
    Figure 12. Oncology & Cancer Drugs Market Drivers
    Figure 13. Factors Affecting Demand
    Figure 14. World Oncology & Cancer Drugs Consumption (2018-2029) & (K Units)
    Figure 15. World Oncology & Cancer Drugs Consumption Market Share by Region (2018-2029)
    Figure 16. United States Oncology & Cancer Drugs Consumption (2018-2029) & (K Units)
    Figure 17. China Oncology & Cancer Drugs Consumption (2018-2029) & (K Units)
    Figure 18. Europe Oncology & Cancer Drugs Consumption (2018-2029) & (K Units)
    Figure 19. Japan Oncology & Cancer Drugs Consumption (2018-2029) & (K Units)
    Figure 20. South Korea Oncology & Cancer Drugs Consumption (2018-2029) & (K Units)
    Figure 21. ASEAN Oncology & Cancer Drugs Consumption (2018-2029) & (K Units)
    Figure 22. India Oncology & Cancer Drugs Consumption (2018-2029) & (K Units)
    Figure 23. Producer Shipments of Oncology & Cancer Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2022
    Figure 24. Global Four-firm Concentration Ratios (CR4) for Oncology & Cancer Drugs Markets in 2022
    Figure 25. Global Four-firm Concentration Ratios (CR8) for Oncology & Cancer Drugs Markets in 2022
    Figure 26. United States VS China: Oncology & Cancer Drugs Production Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 27. United States VS China: Oncology & Cancer Drugs Production Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Oncology & Cancer Drugs Consumption Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. United States Based Manufacturers Oncology & Cancer Drugs Production Market Share 2022
    Figure 30. China Based Manufacturers Oncology & Cancer Drugs Production Market Share 2022
    Figure 31. Rest of World Based Manufacturers Oncology & Cancer Drugs Production Market Share 2022
    Figure 32. World Oncology & Cancer Drugs Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 33. World Oncology & Cancer Drugs Production Value Market Share by Type in 2022
    Figure 34. Chemotherapy
    Figure 35. Targeted Therapy
    Figure 36. Immunotherapy (Biologic Therapy)
    Figure 37. Hormonal Therapy
    Figure 38. Others
    Figure 39. World Oncology & Cancer Drugs Production Market Share by Type (2018-2029)
    Figure 40. World Oncology & Cancer Drugs Production Value Market Share by Type (2018-2029)
    Figure 41. World Oncology & Cancer Drugs Average Price by Type (2018-2029) & (US$/Unit)
    Figure 42. World Oncology & Cancer Drugs Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 43. World Oncology & Cancer Drugs Production Value Market Share by Application in 2022
    Figure 44. Blood Cancer
    Figure 45. Breast Cancer
    Figure 46. Gastrointestinal Cancer
    Figure 47. Prostate Cancer
    Figure 48. Respiratory/Lung Cancer
    Figure 49. Others
    Figure 50. World Oncology & Cancer Drugs Production Market Share by Application (2018-2029)
    Figure 51. World Oncology & Cancer Drugs Production Value Market Share by Application (2018-2029)
    Figure 52. World Oncology & Cancer Drugs Average Price by Application (2018-2029) & (US$/Unit)
    Figure 53. Oncology & Cancer Drugs Industry Chain
    Figure 54. Oncology & Cancer Drugs Procurement Model
    Figure 55. Oncology & Cancer Drugs Sales Model
    Figure 56. Oncology & Cancer Drugs Sales Channels, Direct Sales, and Distribution
    Figure 57. Methodology
    Figure 58. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Related Reports

Global Oncology & Cancer Drugs Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Oncology & Cancer Drugs Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 10 Jan 2023

date Pharma & Healthcare

Cancer is the name given to a group of related diseases characterized by the uncontrolled and excessive growth of abnormal cells. More than 200 different types of cancer have been identified. When these extra cells form a mass or a solid lump of tissue, it is called a tumor. Most cancers form tumors, but not all do. Tumors may be either benign or cancerous.

Global Oncology & Cancer Drugs Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Oncology & Cancer Drugs Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Oncology & Cancer Drugs market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Global Oncology & Cancer Drugs Supply, Demand and Key Producers, 2024-2030

Global Oncology & Cancer Drugs Supply, Demand and Key Producers, 2024-2030

date 08 Feb 2024

date Pharma & Healthcare

The global Oncology & Cancer Drugs market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

Product Tags

oncology/cancer drugs

oncology cancer drugs

Oncology & Cancer Drugs

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>